glp-1 safe Medications: Everything You Need to Know Achieve Safe & Successful Weight

GLP-1s for Chronic Kidney Disease GLP-1s for Advanced Liver Disease In August 2025, the FDA approved Wegovy (semaglutide) to treat adults with a type of liver disease called metabolic-associated steatohepatitis (MASH) with moderate to advanced liver scarring (fibrosis), when used alongside diet and exercise

Dietary supplements have not undergone comparable testing

Understanding what to expect may help people use these drugs more easily and confidently

Bell RA, Jones-Vessey K, Summerson JH

However, the immediate barriers to adoption of these drugs may lie not in their side effect profile, but rather in the ability of our physicians and healthcare system to accept them